Ultrasonographic Evaluation of Morphological and Functional Characteristics of Intercostal Muscle… (NCT07670585) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Ultrasonographic Evaluation of Morphological and Functional Characteristics of Intercostal Muscles in Stroke Patients and Their Relationship With Clinical Parameters
Turkey (Türkiye)65 participantsStarted 2026-07-15
Plain-language summary
The aim of this study is to evaluate the morphological and functional characteristics of parasternal intercostal muscles in patients with stroke using ultrasonography. Parasternal intercostal muscle thickness and thickening fraction will be assessed on both the hemiplegic and non-hemiplegic sides. The relationship between ultrasonographic findings and respiratory muscle strength, motor function, balance, functional independence, and quality of life will also be investigated. A healthy control group will be included to establish reference values and enable comparative analyses.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria (Stroke Group):
* Age between 18 and 75 years.
* History of ischemic or hemorrhagic stroke.
* Ability to understand and comply with study procedures.
* Provision of written informed consent.
Exclusion Criteria (Stroke Group):
* Presence of acute or chronic pulmonary disease.
* History of thoracic or abdominal surgery.
* Presence of another neuromuscular disorder.
* Aphasia or cognitive impairment preventing participation in assessments.
* Active malignancy.
Inclusion Criteria (Healthy Control Group):
* Age between 18 and 75 years.
* Willingness to participate in the study.
* Provision of written informed consent.
Exclusion Criteria (Healthy Control Group):
* History of stroke or other neurological disorders.
* History of chronic respiratory disease (e.g., COPD, asthma).
* Chest wall deformity.
* Presence of systemic diseases that may affect muscle function.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.